1. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial. (28th September 2016) Authors: Boswood, A.; Häggström, J.; Gordon, S.G.; Wess, G.; Stepien, R.L.; Oyama, M.A.; Keene, B.W.; Bonagura, J.; MacDonald, K.A.; Patteson, M.; Smith, S.; Fox, P.R.; Sanderson, K.; Woolley, R.; Szatmári, V.; Menaut, P.; Church, W.M.; O'Sullivan, M. L.; Jaudon, J.‐P.; Kresken, J.‐G. Journal: Journal of veterinary internal medicine Issue: Volume 30:Number 6(2016:Nov./Dec.) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study. (6th December 2017) Authors: Boswood, A.; Gordon, S.G.; Häggström, J.; Wess, G.; Stepien, R.L.; Oyama, M.A.; Keene, B.W.; Bonagura, J.; MacDonald, K.A.; Patteson, M.; Smith, S.; Fox, P.R.; Sanderson, K.; Woolley, R.; Szatmári, V.; Menaut, P.; Church, W.M.; O'Sullivan, M.L.; Jaudon, J.‐P.; Kresken, J.‐G. Journal: Journal of veterinary internal medicine Issue: Volume 32:Number 1(2018) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗